101 related articles for article (PubMed ID: 6353806)
41. [Humoral and cellular anticollagen autoimmunity in rheumatic pathology].
Gioud M; Monier JC; Bonvoisin B; Meghlaoui A; Venet C; Lejeune E; Bouvier M
Rev Rhum Mal Osteoartic; 1983; 50(8-9):579-83. PubMed ID: 6356308
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of leukocyte migration by tumor-associated antigen and its modification by serum; IgA as a blocking factor.
Sipos J; Gábor V; Tóth Z
Neoplasma; 1978; 25(2):181-8. PubMed ID: 643122
[TBL] [Abstract][Full Text] [Related]
43. Differences in alpha smooth muscle actin expression between fibroblasts derived from Dupuytren's nodules or cords.
Dave SA; Banducci DR; Graham WP; Allison GM; Ehrlich HP
Exp Mol Pathol; 2001 Oct; 71(2):147-55. PubMed ID: 11599921
[TBL] [Abstract][Full Text] [Related]
44. Prevalence of HLA-DR3 and autoantibodies to connective tissue components in Dupuytren's contracture.
Neumüller J; Menzel J; Millesi H
Clin Immunol Immunopathol; 1994 May; 71(2):142-8. PubMed ID: 8181183
[TBL] [Abstract][Full Text] [Related]
45. [A novel method for screening anti-inner ear autoantibody in patients with autoimmune diseases].
Zou J; Bi A; Wu X; Yang W; Li Z
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Apr; 35(2):113-6. PubMed ID: 12768666
[TBL] [Abstract][Full Text] [Related]
46. Humoral and cellular immunity in sarcoidosis.
Veien NK; Hardt F; Bendixen G; Genner J; Ringsted J; Wanstrup J; Wiik A; Christiansen E
Acta Med Scand; 1978; 203(4):321-6. PubMed ID: 645446
[TBL] [Abstract][Full Text] [Related]
47. Epidermal growth factor receptor (EGF-R) in Dupuytren's disease.
Augoff K; Taboła R; Kula J; Gosk J; Rutowski R
J Hand Surg Br; 2005 Dec; 30(6):570-3. PubMed ID: 16055243
[TBL] [Abstract][Full Text] [Related]
48. [The place of the leukocyte migration inhibition test in studying immunopathogenetic mechanisms in acute articular rheumatism].
Debeleac L; Ungureanu I; Georgescu M
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1986; 31(3):253-62. PubMed ID: 3787085
[No Abstract] [Full Text] [Related]
49. [The treatment of Dupuytren's contracture. A social medical problem (author's transl)].
Vogt HJ; Hochschau L
MMW Munch Med Wochenschr; 1980 Jan; 122(4):125-30. PubMed ID: 6767935
[TBL] [Abstract][Full Text] [Related]
50. [Autoimmune aspects of a case of chronic interstitial cystitis].
Leonardo E; Dogliotti C; Navone R
Minerva Med; 1986 Jun; 77(27):1323-6. PubMed ID: 3523308
[TBL] [Abstract][Full Text] [Related]
51. Dupuytren's contracture and sarcoma.
Wilbrand S; Ekbom A; Gerdin B
J Hand Surg Br; 2002 Feb; 27(1):50-2. PubMed ID: 11895346
[TBL] [Abstract][Full Text] [Related]
52. [Tuberculin sensitivity tests, using leukocyte migration inhibition, in patients with autoimmune diseases undergoing immunosuppressive therapy].
Szabó G; Szegedi G; Gergely P; Fekete B; Petrányi G
Orv Hetil; 1973 Aug; 114(32):1914-7. PubMed ID: 4581535
[No Abstract] [Full Text] [Related]
53. Cellular structure and biology of Dupuytren's disease.
Tomasek JJ; Vaughan MB; Haaksma CJ
Hand Clin; 1999 Feb; 15(1):21-34. PubMed ID: 10050239
[TBL] [Abstract][Full Text] [Related]
54. [Proceedings: Cellular immunity in autoimmune thyroid diseases: leukocyte migration inhibition (LMI) test].
Amino N; DeGroot LJ
Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):561. PubMed ID: 4476569
[No Abstract] [Full Text] [Related]
55. [Cellular phenomena of autoallergy in pneumonia patients].
Basova LI
Zdravookhr Kirg; 1976; (3):18-20. PubMed ID: 7894
[No Abstract] [Full Text] [Related]
56. Imiquimod: a potential weapon against Dupuytren contracture.
Namazi H
Med Hypotheses; 2006; 66(5):991-2. PubMed ID: 16368197
[TBL] [Abstract][Full Text] [Related]
57. [3-HAA-antigen and immunoreactivity indices in patients with bladder tumors].
Korosteleva TA; Rabkova LM; Belokhvostova AT; Movsesian KS; Skadova VM
Vopr Onkol; 1986; 32(9):48-53. PubMed ID: 3765523
[TBL] [Abstract][Full Text] [Related]
58. Migration inhibition studies in human disease.
Brostoff J
Proc R Soc Med; 1970 Sep; 63(9):905-6. PubMed ID: 5536331
[No Abstract] [Full Text] [Related]
59. [Humoral and cellular manifestations of immunity in scoliotic disease].
Delevskiĭ IuP; Khavkina LV; Shevchenko SD; Bezvesil'naia GV; Gavrilina LV
Ortop Travmatol Protez; 1978 Apr; (4):8-13. PubMed ID: 652309
[No Abstract] [Full Text] [Related]
60. Assessment of autoantigenic activity of hepatic tissue components.
Bull DM
Gastroenterology; 1976 Jul; 71(1):164-6. PubMed ID: 776734
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
